Ayass BioScience, LLC

09/13/2026

New Research: Selective Thrombin Modulation with AYA1809002

AYA1809002 is a novel Exosite I-targeting DNA aptamer designed for selective, stable, and reversible thrombin modulation.

The study demonstrates potent inhibition of key procoagulant thrombin functions while preserving thrombomodulin-dependent protein C activation. AYA1809002 also showed strong functional stability and rapid, sequence-specific reversal of its anticoagulant activity.

These findings highlight a promising approach to more precisely controlled anticoagulation.

Selective. Stable. Reversible.

Background: Thrombin is a central mediator of coagulation and platelet activation and a key anticoagulant target. Direct thrombin inhibitors broadly suppress thrombin proteolytic activity, potentially disrupting procoagulant and anticoagulant signaling. Exosite-targeting aptamers may enable selectiv...

09/05/2026

Disease biology is complex. The challenge is finding what actually drives it.

BiRAGAS moves beyond association to uncover causal drivers - helping turn biological complexity into actionable insight.

Find the driver. Change the outcome.

08/30/2026

Disease is what we see.
The biology behind it is far more complex.

BiRAGAS connects biological signals to uncover the causal drivers of disease—turning complexity into direction for therapeutic impact.

08/28/2026

Disease data is full of signals.
But signals alone don’t reveal what drives disease.

BiRAGAS moves beyond correlation to identify causal direction—helping turn complex biological data into actionable insight.

From correlation to causation. From signals to direction.

08/26/2026

Disease has a name. But a name doesn’t tell us why it happens.

BiRAGAS moves beyond associations to uncover the causal drivers behind disease—turning biological complexity into therapeutic intelligence.

From complexity to causality.

08/24/2026

Complex biology creates thousands of signals. But which ones actually drive disease?

BiRAGAS moves beyond patterns and associations to uncover the causal relationships that matter.

From biological complexity to causal understanding.

08/22/2026

Finding patterns is only the beginning.

BiRAGAS goes beyond associations and correlations to uncover the causal drivers behind disease - turning complex biological data into actionable therapeutic intelligence.

Find what matters. Focus on cause. Drive cures.

08/21/2026

Disease is what we see. But what’s actually driving it?

BiRAGAS goes beyond biological associations to uncover the causal drivers of disease - connecting genes, proteins, pathways, cellular context, environment, and clinical data.

Because understanding the cause is the first step toward meaningful therapeutic impact.

08/20/2026

Thousands of biological signals can point in thousands of directions.
But which path is actually driving disease?
BiRAGAS moves beyond association to identify the causal relationships that matter.
From complexity to causality.

08/19/2026

Every disease leaves clues. The challenge is connecting them.

BiRAGAS brings complex biological data together to move from association toward causality.